CenterBook Partners »

Travere Therapeutics shares owned by CenterBook Partners

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by CenterBook Partners from 13F filings

Historical chart of CenterBook Partners investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by CenterBook Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by CenterBook Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.7M 157k 29.71

More positions owned by CenterBook Partners

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Applied Materials (AMAT)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Amphenol Corp Cl A (APH)
Advanced Micro Devices (AMD)

View all positions for CenterBook Partners

Top funds holding Travere Therapeutics

Henderson Group
FMR
BlackRock
Vanguard Group
Armistice Capital
State Street Corporation
Perceptive Advisors
Vanguard Capital Management
Nomura Asset Management International
Adage Capital Partners GP
Kynam Capital Management
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Goldman Sachs Group

View all funds holding Travere Therapeutics